Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225273 · ClinicalTrials.gov registry record · NA
Extension Study for 43USSA1705
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT04225273 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 38 participants.
The verdict
NCT04225273, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
To evaluate the long-term safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.
Interventions
- DEVICE Sculptra Aesthetic, Lidocaine HCL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-12-03 |
| Est. Completion | 2021-01-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04225273
The ClinicalTrials.gov registry entry for NCT04225273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sculptra Aesthetic, Lidocaine HCL is the first listed.
NCT04225273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04225273 about?
NCT04225273 is a clinical study titled "Extension Study for 43USSA1705". To evaluate the long-term safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.
What is the current status of trial NCT04225273?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-12-03. Estimated completion is 2021-01-29.
What interventions are being tested in trial NCT04225273?
The interventions under investigation include: Sculptra Aesthetic, Lidocaine HCL (DEVICE).
Who is sponsoring clinical trial NCT04225273?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.